News

CRITICARE, February 15-19, Pune, India January 24 2012

Conference on Continuous Renal Replacement Therapies (CRRT), February 12-15, San Diego, USA January 24 2012

MEDLAB, Arab Health, January 23-26, Dubai, UAE January 16 2012

An addition to the Obesity and Type 2 Diabetes antibody portfolio December 22 2011

Better kidney markers ahead? December 05 2011

New NGAL.com website launched November 24 2011

MEDICA, November 16-19, Düsseldorf, Germany October 26 2011

ASN Kidney Week, November 8-13, Pennsylvania, Philadelphia, USA October 20 2011

ESICM 2011, October 1-5, Berlin, Germany September 06 2011

AACC Clinical Lab Expo, July 24-28, Atlanta July 04 2011

next 10

MEDICA, November 18-21, Düsseldorf, Germany

November 09 2009 by Ana Belén Enfedaque Buisán

As the world’s largest medical trade fair, this year’s MEDICA once again offers a comprehensive overview of a wide variety of innovations in the world of healthcare. This leading medical fair gives decision makers from around the world the opportunity to find out about the latest developments in their field and to discuss their field of specialization.

BioPorto Diagnostics will participate in MEDICA showcasing The NGAL Test as well as the latest developments in its portfolio.

Meet us at stand K88, Hall 3:

Trine Østerbye, Sales and Marketing Manager toe@bioporto.com

Ishan Gupta, Business Development Manager Sales ig@bioporto.com

Jakob Ohm Eriksen, Pharma Diagnostics Product Manager joe@bioporto.com

Klaus Boberg Pedersen, Human Diagnostics Product Manager kbp@bioporto.com

Ana Belén Enfedaque, Marketing Coordinator aeb@bioporto.com

For further information on MEDICA, please click here

DISTRIBUTOR MEETING 2009

Following the highly successful 2008 meeting, MEDICA, the hub of the medical trade, will once again become the meeting point for our distributors this year. In a plenary session which will be held on Tuesday, November, 17, we will not only share knowledge for the development of our present business partnerships but also discuss both product and market potential in the different territories in which our products are commercialized.